Fluticasone Propionate Powder, Metered
Product Images NDC 50090-7962

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 50090-7962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasone Propionate Diskus Spl Graphic 01)

Chemical structure diagram of fluticasone propionate, showing the arrangement of atoms and bonds characteristic of this corticosteroid compound.*

FDA Label Image

Figure 1 (Fluticasone Propionate Diskus Spl Graphic 02)

A line graph comparing the percent change from baseline in FEV1 over 12 weeks between Fluticasone Propionate DISKUS 100 mcg twice daily and placebo. The x-axis represents weeks from 0 to 12 and the y-axis shows percent change from baseline FEV1. Fluticasone shows a greater increase than placebo throughout the study period.*

FDA Label Image

Figure 2 (Fluticasone Propionate Diskus Spl Graphic 03)

A line graph depicting the percentage change from baseline in FEV1 (lung function) over 12 weeks. It compares two groups: patients using Fluticasone Propionate DISKUS 100 mcg twice daily and those receiving placebo. The x-axis represents weeks, and the y-axis indicates percentage change in baseline FEV1, showing greater improvement with Fluticasone Propionate DISKUS.*

FDA Label Image

Figure 3 (Fluticasone Propionate Diskus Spl Graphic 04)

A line graph showing percent change from baseline in FEV1 over 12 weeks for Fluticasone Propionate DISKUS 250 mcg twice daily and placebo groups. The x-axis represents weeks, and the y-axis represents percent change from baseline in FEV1. Two lines compare the treatment and placebo groups' lung function changes during the study.*

FDA Label Image

Figure 4 (Fluticasone Propionate Diskus Spl Graphic 05)

A line graph comparing the percentage change from baseline in FEV1 over 12 weeks between Fluticasone Propionate DISKUS 500 mcg twice daily and placebo. The x-axis represents weeks from 0 to 12, and the y-axis shows percentage change from baseline in FEV1. Two lines represent treatment groups, with Fluticasone Propionate showing a higher percentage improvement than placebo.*

FDA Label Image

Figure A (Fluticasone Propionate Diskus Spl Graphic 06)

Illustration of the FLUTICASONE PROPIONATE DISKUS 100 mcg metered powder inhalation device by A-S Medication Solutions. The labeled parts include the outer case, mouthpiece, lever, thumb grip, and dose counter, showing the inhaler's components for delivering fluticasone propionate powder. The label on the device indicates a 60-blister count with a 100 mcg strength.*

FDA Label Image

Figure B (Fluticasone Propionate Diskus Spl Graphic 07)

Illustration showing a person holding a FLUTICASONE PROPIONATE DISKUS inhaler device, demonstrating how to operate it by pushing the lever indicated by a white arrow to release the medication powder for respiratory inhalation.*

FDA Label Image

Figure C (Fluticasone Propionate Diskus Spl Graphic 08)

An illustration showing a hand holding a round inhaler device, demonstrating usage by indicating the pressing of the inhaler with an arrow pointing outward, related to FLUTICASONE PROPIONATE DISKUS inhalation powder.*

FDA Label Image

Figure D (Fluticasone Propionate Diskus Spl Graphic 09)

An instructional illustration showing a woman holding a red disk inhaler near her mouth, demonstrating its use for respiratory inhalation of medication.*

FDA Label Image

Figure E (Fluticasone Propionate Diskus Spl Graphic 10)

An illustration showing a woman holding and using a red fluticasone propionate inhaler device (Diskus) to administer a powdered dose through inhalation. The image demonstrates the respiratory route of the powder, metered dosage form of the medication.*

FDA Label Image

Figure F (Fluticasone Propionate Diskus Spl Graphic 11)

An instructional illustration showing hands holding a fluticasone propionate inhaler device, demonstrating the step of sliding the lever to prepare the inhaler for use, indicated by an arrow pointing horizontally to the left.*

FDA Label Image

Figure G (Fluticasone Propionate Diskus Spl Graphic 12)

An illustration showing a woman rinsing her mouth with water over a sink, with a glass of water nearby. The image likely depicts post-inhalation oral rinsing, related to respiratory powder medications such as inhaled fluticasone propionate.*

FDA Label Image

Figure H (Fluticasone Propionate Diskus Spl Graphic 13)

FLUTICASONE PROPIONATE DISKUS inhaler device labeled for Fluticasone Propionate Inhalation Powder 100 mcg, containing 60 blisters. The device is reddish-orange with a circular white label displaying the strength and dosage form. It includes a dose counter showing 5 remaining doses and instructions for use after opening.*

FDA Label Image

Label Image (Lbl500907962)

Label of FLUTICASONE PROPIONATE DISKUS 100 microgram per inhalation powder, metered dose by A-S Medication Solutions. The label includes instructions to protect the device from heat or sunlight and details about the powder inhalation device, including dosage and package insert information. The label also lists the product NDC 50090-7962-0 and distributor information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.